Pfizer-BioNTech COVID-19 Vaccine Fact Sheet

On December 11, 2020, the U.S. Food and Drug Administration issued the first emergency use authorization (EUA) for a vaccine for the prevention of COVID-19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 16 years of age and older. The emergency use authorization allows the Pfizer-BioNTech COVID-19 Vaccine to be distributed in the U.S. On May 12, 2021, individuals 12-15 years of age became eligible to receive the Pfizer-BioNTech vaccine following decisions by the FDA, CDC, and the Missouri DHSS.

Publication Date: 01/26/2021
Document Type: Informational Pages
Sponsor: Department of Health

Fact sheets available in the following languages.
English, Arabic, Bosnian, Nepali, Russian, Chinese (Simplified), Spanish, Swahili, Vietnamese

For additional languages, please visit

Need Help Viewing?

You need a program that can open Adobe PDF files. A free option:

Was this page helpful?      

Comments are helpful!
500 character limit

Feedback is anonymous.